{"title":"Sex Differences in Quality of Life and Clinical Outcomes in Patients with Heart Failure","authors":"Jingxuan Liu, Zhou Lu, Wan Xuesi, Jianzeng Dong","doi":"10.15212/cvia.2023.0046","DOIUrl":null,"url":null,"abstract":"Background: Heart failure (HF) is generally associated with poor quality of life (QoL). Limited data are available characterizing health-related QoL (HRQL) in Chinese patients with HF. Methods: We used the Minnesota Living with Heart Failure Questionnaire (MLHFQ) to record QoL in 4082 patients with HF from China who were followed up over 12 months in the Heart Failure Registry of Patient Outcomes (HERO) study. Baseline HRQL and differences in QoL between women and men with heart failure were compared. We used multivariable Cox regression with adjustment for variables to assess the association between MLHFQ summary scores and a composite of all-cause mortality and HF hospitalization. Result: At baseline, the mean MLHFQ in the overall population was 42.9 ± 19.57; the scores for physical and emotional domains were 22.0 ± 8.69 and 8.66 ± 6.08, respectively. Women had a higher (poorer) MLHFQ summary score (44.27 ± 19.13) than men (41.63 ± 19.90) (P<0.001). Female patients also had higher MLHFQ physical and emotional scores than male patients (P<0.001). The specific scores of the questionnaire were higher in women than men. NYHA class was the strongest independent predictor of MLHFQ score (β=6.12 unit increment; P<0.001). Sex was not independently associated with higher MLHFQ scores after multivariable adjustments. The 12-month mortality in the overall cohort was 19.6%, the hospitalization rate was 24.4%, and the composite endpoint was 40.15%. A 10-point increase in MLHFQ score was associated with higher risk of mortality (female and male HRs=1.19 [95% CI 1.12–1.26]; P<0.001 and 1.18 [95% CI 1.12–1.24]; P<0.001, respectively) and composite outcomes (HRs=1.08 [95% CI 1.04–1.13]; P<0.001 and 1.11 [95% CI 1.07–1.14]; P<0.001, respectively). Females did not show a significant association between HRQL and hospitalization (HR=1.04 [95% CI 0.99–1.09]; P=0.107). Conclusion: Quality of life was largely poorer in women than men, but was similar between sexes in terms of physical burden and emotional limitation. HRQL is an independent predictor of all-cause death and HF hospitalization in patients with HF.","PeriodicalId":41559,"journal":{"name":"Cardiovascular Innovations and Applications","volume":"1 1","pages":""},"PeriodicalIF":0.9000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Innovations and Applications","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15212/cvia.2023.0046","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Heart failure (HF) is generally associated with poor quality of life (QoL). Limited data are available characterizing health-related QoL (HRQL) in Chinese patients with HF. Methods: We used the Minnesota Living with Heart Failure Questionnaire (MLHFQ) to record QoL in 4082 patients with HF from China who were followed up over 12 months in the Heart Failure Registry of Patient Outcomes (HERO) study. Baseline HRQL and differences in QoL between women and men with heart failure were compared. We used multivariable Cox regression with adjustment for variables to assess the association between MLHFQ summary scores and a composite of all-cause mortality and HF hospitalization. Result: At baseline, the mean MLHFQ in the overall population was 42.9 ± 19.57; the scores for physical and emotional domains were 22.0 ± 8.69 and 8.66 ± 6.08, respectively. Women had a higher (poorer) MLHFQ summary score (44.27 ± 19.13) than men (41.63 ± 19.90) (P<0.001). Female patients also had higher MLHFQ physical and emotional scores than male patients (P<0.001). The specific scores of the questionnaire were higher in women than men. NYHA class was the strongest independent predictor of MLHFQ score (β=6.12 unit increment; P<0.001). Sex was not independently associated with higher MLHFQ scores after multivariable adjustments. The 12-month mortality in the overall cohort was 19.6%, the hospitalization rate was 24.4%, and the composite endpoint was 40.15%. A 10-point increase in MLHFQ score was associated with higher risk of mortality (female and male HRs=1.19 [95% CI 1.12–1.26]; P<0.001 and 1.18 [95% CI 1.12–1.24]; P<0.001, respectively) and composite outcomes (HRs=1.08 [95% CI 1.04–1.13]; P<0.001 and 1.11 [95% CI 1.07–1.14]; P<0.001, respectively). Females did not show a significant association between HRQL and hospitalization (HR=1.04 [95% CI 0.99–1.09]; P=0.107). Conclusion: Quality of life was largely poorer in women than men, but was similar between sexes in terms of physical burden and emotional limitation. HRQL is an independent predictor of all-cause death and HF hospitalization in patients with HF.
背景:心力衰竭(HF)通常与较差的生活质量(QoL)相关。有关中国心衰患者健康相关生活质量(HRQL)的资料有限。方法:我们使用明尼苏达州心力衰竭患者生活问卷(MLHFQ)记录4082名中国心力衰竭患者的生活质量,这些患者在心力衰竭患者结局登记(HERO)研究中随访超过12个月。比较女性和男性心力衰竭患者的基线HRQL和生活质量差异。我们使用多变量Cox回归对变量进行校正,以评估MLHFQ综合评分与全因死亡率和心衰住院率之间的关系。结果:基线时,总体人群MLHFQ均值为42.9±19.57;生理和情绪领域得分分别为22.0±8.69分和8.66±6.08分。女性MLHFQ综合评分(44.27±19.13)高于男性(41.63±19.90)(P<0.001)。女性患者的MLHFQ生理和情绪评分也高于男性患者(P<0.001)。女性的问卷具体得分高于男性。NYHA分级是MLHFQ评分的最强独立预测因子(β=6.12单位增量;P < 0.001)。在多变量调整后,性别与更高的MLHFQ分数没有独立的关联。整个队列的12个月死亡率为19.6%,住院率为24.4%,综合终点为40.15%。MLHFQ评分每增加10分,死亡风险就会增加(女性和男性hr =1.19 [95% CI 1.12-1.26];P<0.001和1.18 [95% CI 1.12-1.24];P<0.001)和综合结果(hr =1.08 [95% CI 1.04-1.13];P<0.001和1.11 [95% CI 1.07-1.14];分别为P < 0.001)。女性患者HRQL与住院治疗无显著相关性(HR=1.04 [95% CI 0.99-1.09];P = 0.107)。结论:女性的生活质量明显低于男性,但在身体负担和情感限制方面,性别差异不大。HRQL是心衰患者全因死亡和心衰住院的独立预测因子。